Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Response to Treatment With Immunotherapy + Chemotherapy in Non-Small Cell Lung Cancer

NCT04589013 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT04589013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04589013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Response to Treatment With Immunotherapy + Chemotherapy in Non-Small Cell Lung Cancer
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Completed
Start date
November 19, 2020
Completion date
September 29, 2023
Enrollment
106 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer